• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ozagrel Hydrochloride

Ozagrel Hydrochloride

Product ID O9702
Cas No. 82571-53-7
Purity ≥98%
Product Unit SizeCostQuantityStock
10 mg $102.00 In stock
25 mg $204.30 In stock
100 mg $653.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ozagrel is an inhibitor of thromboxane A2 (TxA2) synthase that displays antithrombotic, anti-asthma, and anti-allergic activities. In vivo, ozagrel decreases airway responses to inhalation of leukotriene C4 (LTC4) and TxA2 analog STA2, inhibiting secondary release of TxA2. In other animal models of bronchoconstriction, ozagrel increases levels of prostaglandin I2 (PGI2), inhibiting histamine release. In clinical settings, ozagrel decreases airway contraction in subjects with exercise-induced asthma. In diabetic mice, this compound inhibits retinal arteriolar constriction, preventing decreases in retinal blood flow associated with diabetes-induced retinopathy. Additionally, ozagrel displays cardioprotective activity, decreasing infarct size and thrombus formation in animal models of ischemia-induced myocardial injury. Ozagrel is also hepatoprotective, inhibiting expression of Jun, Fos, and C/EBP homologous protein (CHOP), preventing acetaminophen-induced liver injury.

Product Info

Cas No.

82571-53-7

Purity

≥98%

Formula

C13H12N2O2 • HCl

Formula Wt.

264.71

IUPAC Name

(E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid

Synonym

3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2E-propenoic acid, OKY-046

Appearance

White powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

O9702 MSDS PDF

Info Sheet

O9702 Info Sheet PDF

References

Sathler PC, Santana M, Lourenço AL, et al. Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel. J Enzyme Inhib Med Chem. 2013 Aug 5. Epub ahead of print. PMID: 23914925.

Tomishima Y, Ishitsuka Y, Matsunaga N, et al. Ozagrel hydrochloride, a selective thromboxane A2 synthase inhibitor, alleviates liver injury induced by acetaminophen overdose in mice. BMC Gastroenterol. 2013 Jan 30;13:21. PMID: 23363429.

Lee S, Morgan GA, Harris NR. Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina. Microvasc Res. 2008 Nov;76(3):217-23. PMID: 18718478.

Fujimura M, Ogawa H, Saito M, et al. Inhibitory effect of inhalation of a thromboxane synthetase inhibitor on bronchoconstriction induced by aerosolized leukotriene C4 and thromboxane A2 analogue in anesthetized guinea pigs. Allergy. 1991 Oct;46(7):534-9. PMID: 1796779.

Hoshino M, Fukushima Y. Effect of OKY-046 (thromboxane A2 synthetase inhibitor) on exercise-induced asthma. J Asthma. 1991;28(1):19-29. PMID: 1849133.

Nambu F, Murakata S, Shiraji T, et al. OKY-046 inhibits anaphylactic bronchoconstriction and reduces histamine level in bronchoalveolar lavage fluid in sensitized guinea pigs. Prostaglandins. 1990 Jun;39(6):623-37. PMID: 1695383.

Tomoda H. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046). Am Heart J. 1986 Oct;112(4):696-704. PMID: 3532743.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T7197

    Tryprostatin A

    Diketopiperazine produced by Aspergillus; micro...

    ≥92%
  • P6852

    Propafenone Hydrochloride

    β-adrenergic antagonist, Kv1.4 and K2P2 K+ cha...

    ≥98%
  • L1878

    Letrozole

    Aromatase inhibitor.

    ≥98%
  • K0030

    Kahweol

    Diterpene found in coffee beans.

    ≥97%
  • P1917

    Phenylethyl 3-methylcaffeate

    Derivative of methyl caffeate, hydroxycinnamic ...

    ≥97%
  • A9914

    AZD-8055

    mTOR inhibitor.

    ≥98%
  • Y4802

    YM-201636

    PIKfyve inhibitor.

    ≥98%
  • T564098

    Tocored

    Tocopherol analog

  • P7219

    Pseudolaric Acid B

    Diterpene acid found in Pseudolarix kaempferi.<...

    ≥98%
  • M4452

    MLN2480

    Raf inhibitor.

    ≥98%
  • L1782

    Levodopa

    Endogenous catecholamine precursor, also found ...

    ≥98%
  • P2100

    PF-06447475

    LRRK2 inhibitor.

    ≥98%
  • H9863

    Hyperforin Dicyclohexylammonium

    Stable salt form of hyperforin, a compound foun...

    ≥97%
  • D364086

    Decernotinib

    JAK3 inhibitor.

    ≥99%
  • P200002

    PF-07321332

    Inhibitor of coronaviruses

    ≥99%
  • B1876

    Betamethasone

    Steroid; glucocorticoid agonist.

    ≥98%
  • A0833

    Acipimox

    Niacin derivative.

    ≥98%
  • B1996

    BEZ235

    PI3K and mTOR inhibitor.

    ≥98%
  • M9368

    Myristicin

    Allylbenzene found in spices and umbelliferous ...

    ≥98%
  • S1069

    Scriptaid

    HDAC inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only